Works by Srivastava, Nidhi

Results: 67
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.

    Published in:
    Trials, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s13063-015-0831-x
    By:
    • Joline de Groof, E.;
    • Buskens, Christianne J.;
    • Ponsioen, Cyriel Y.;
    • Dijkgraaf, Marcel G. W.;
    • D'Haens, Geert R. A. M.;
    • Srivastava, Nidhi;
    • van Acker, Gijs J. D.;
    • Jansen, Jeroen M.;
    • Gerhards, Michael F.;
    • Dijkstra, Gerard;
    • Lange, Johan F. M.;
    • Witteman, Ben J. M.;
    • Kruyt, Philip M.;
    • Pronk, Apollo;
    • van Tuyl, Sebastiaan A. C.;
    • Bodelier, Alexander;
    • Crolla, Rogier M. P. H.;
    • West, Rachel L.;
    • Vrijland, Wietske W.;
    • Consten, Esther C. J.
    Publication type:
    Article
    24

    Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.

    Published in:
    2015
    By:
    • de Groof, E Joline;
    • Buskens, Christianne J;
    • Ponsioen, Cyriel Y;
    • Dijkgraaf, Marcel G W;
    • D'Haens, Geert R A M;
    • Srivastava, Nidhi;
    • van Acker, Gijs J D;
    • Jansen, Jeroen M;
    • Gerhards, Michael F;
    • Dijkstra, Gerard;
    • Lange, Johan F M;
    • Witteman, Ben J M;
    • Kruyt, Philip M;
    • Pronk, Apollo;
    • van Tuyl, Sebastiaan A C;
    • Bodelier, Alexander;
    • Crolla, Rogier M P H;
    • West, Rachel L;
    • Vrijland, Wietske W;
    • Consten, Esther C J
    Publication type:
    journal article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Frailty Screening is Associated with Hospitalization and Decline in Quality of Life and Functional Status in Older Patients with Inflammatory Bowel Disease.

    Published in:
    Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 516, doi. 10.1093/ecco-jcc/jjad175
    By:
    • Asscher, Vera E R;
    • Gírondo, Mar Rodriguez;
    • Fens, Jesse;
    • Waars, Sanne N;
    • Stuyt, Rogier J L;
    • Baven-Pronk, A Martine C;
    • Srivastava, Nidhi;
    • Jacobs, Rutger J;
    • Haans, Jeoffrey J L;
    • Meijer, Lennart J;
    • Klijnsma-Slagboom, Jacqueline D;
    • Duin, Marijn H;
    • Peters, Milou E R;
    • Lee-Kong, Felicia V Y L;
    • Provoost, Nanda E;
    • Tijdeman, Femke;
    • Dijk, Kenan T van;
    • Wieland, Monse W M;
    • Verstegen, Mirre G M;
    • Meijs, Melissa E van der
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 5, p. 1189, doi. 10.1002/cpt.1712
    By:
    • Biemans, Vince B.C.;
    • Woude, C. Janneke;
    • Dijkstra, Gerard;
    • Meulen‐de Jong, Andrea E.;
    • Oldenburg, Bas;
    • Boer, Nanne K.;
    • Löwenberg, Mark;
    • Srivastava, Nidhi;
    • Bodelier, Alexander G.L.;
    • West, Rachel L.;
    • Jansen, Jeroen M.;
    • Vries, Annemarie C.;
    • Haans, Jeoffrey J.L.;
    • Jong, Dirk J.;
    • Pierik, Marie J.;
    • Hoentjen, Frank
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 1, p. 117, doi. 10.1111/apt.17248
    By:
    • Straatmijer, Tessa;
    • van Schaik, Fiona D. M.;
    • Bodelier, Alexander G. L.;
    • Visschedijk, Marijn;
    • de Vries, Annemarie C.;
    • Ponsioen, Cyriel Y.;
    • Pierik, Marieke;
    • van Bodegraven, Ad A.;
    • West, Rachel L.;
    • de Boer, Nanne K. H.;
    • Srivastava, Nidhi;
    • Romkens, Tessa E. H.;
    • Hoekstra, Jildou;
    • Oldenburg, Bas;
    • Dijkstra, Gerard;
    • van der Woude, Janneke C.;
    • Löwenberg, Mark;
    • Mujagic, Zlatan;
    • Biemans, Vince B. C.;
    • van der Meulen‐de Jong, Andrea E.
    Publication type:
    Article
    48

    Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti‐TNF treatment.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 123, doi. 10.1111/apt.15745
    By:
    • Biemans, Vince B. C.;
    • Woude, C. Janneke;
    • Dijkstra, Gerard;
    • Meulen‐de Jong, Andrea E.;
    • Löwenberg, Mark;
    • Boer, Nanne K.;
    • Oldenburg, Bas;
    • Srivastava, Nidhi;
    • Jansen, Jeroen M.;
    • Bodelier, Alexander G. L.;
    • West, Rachel L.;
    • Vries, Annemarie C.;
    • Haans, Jeoffrey J. L.;
    • Jong, Dirk;
    • Hoentjen, Frank;
    • Pierik, Marieke J.
    Publication type:
    Article
    49

    Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 9, p. 880, doi. 10.1111/apt.15689
    By:
    • Biemans, Vince B. C.;
    • Sleutjes, Jasmijn A. M.;
    • Vries, Annemarie C.;
    • Bodelier, Alexander G. L.;
    • Dijkstra, Gerard;
    • Oldenburg, Bas;
    • Löwenberg, Mark;
    • Bodegraven, Adriaan A.;
    • Meulen‐de Jong, Andrea E.;
    • Boer, Nanne K. H.;
    • Srivastava, Nidhi;
    • West, Rachel L.;
    • Römkens, Tessa E. H.;
    • Horjus Talabur Horje, Carmen S.;
    • Jansen, Jeroen M.;
    • Woude, C. Janneke;
    • Hoekstra, Jildou;
    • Weersma, Rinse K.;
    • Schaik, Fiona D. M.;
    • Hoentjen, Frank
    Publication type:
    Article
    50